Forget the drug discovery hype. Here’s how the world’s largest pharma company is seeing a payoff from AI right now.
This week's second new model from OpenAI is built for more complex tasks than GPT-5.3 Instant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results